T Tanabe Selected Research

Y 26763

6/2000

Attenuation of KATP channel-opener induced shortening of repolarization time by alpha 1-adrenoceptor antagonist during ischemia in canine heart.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

T Tanabe Research Topics

Disease

4	Neoplasms (Cancer) 06/2001 - 02/2000
3	Asthma (Bronchial Asthma) 04/2014 - 01/2009
3	Myocardial Infarction 01/2006 - 03/2000
3	Pain (Aches) 11/2001 - 05/2000
3	Carcinogenesis 06/2001 - 09/2000
2	Inflammation (Inflammations) 04/2014 - 09/2000
2	Hyperplasia 12/2011 - 01/2008
2	Autoimmune Pancreatitis 08/2009 - 03/2009
2	Thrombosis (Thrombus) 01/2006 - 01/2000
2	Carcinoma (Carcinomatosis) 12/2001 - 06/2001
2	Type 2 Diabetes Mellitus (MODY) 12/2001 - 10/2000
2	Angina Pectoris 11/2001 - 05/2001
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2001 - 06/2000
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 06/2001 - 04/2000
2	Glioma (Gliomas) 02/2001 - 01/2001
2	Neuroblastoma 02/2001 - 01/2001
2	Atherosclerosis 09/2000 - 02/2000
2	Head and Neck Neoplasms (Head and Neck Cancer) 08/2000 - 05/2000
1	Chronic Subdural Hematoma 01/2022
1	Hematoma 01/2022
1	Intracranial Hypotension 01/2022
1	Acute Subdural Hematoma 07/2021
1	Glucose Intolerance 01/2018
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2018
1	Neutropenia 04/2014
1	Metaplasia 04/2014
1	Seizures (Absence Seizure) 08/2011
1	Pulmonary Sarcoidosis 08/2009
1	Chronic Pancreatitis 03/2009
1	Aneurysm (Aneurysms) 12/2008
1	Wounds and Injuries (Trauma) 08/2006
1	Barotrauma 07/2006
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2006
1	Retinal Neovascularization 07/2006
1	Obesity 01/2006
1	Capsule Opacification 06/2004
1	Osteomyelitis 01/2004
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 08/2003
1	Body Weight (Weight, Body) 05/2003
1	T-Cell Leukemia (Leukemia, T Cell) 12/2001
1	Hyperglycemia 12/2001
1	Insulin Resistance 12/2001
1	Infections 12/2001
1	Diabetes Mellitus 11/2001
1	Neointima 10/2001
1	Takotsubo Cardiomyopathy 08/2001

Drug/Important Bio-Agent (IBA)

6	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2001 - 02/2000
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 03/2000
3	CytokinesIBA 04/2014 - 06/2000
3	Proteins (Proteins, Gene)FDA Link 08/2009 - 03/2000
3	Cisplatin (Platino)FDA LinkGeneric 08/2003 - 05/2000
3	Fluorouracil (Carac)FDA LinkGeneric 08/2003 - 05/2000
3	Calcium Channels (Calcium Channel)IBA 12/2001 - 04/2000
2	Interleukin-13IBA 12/2011 - 01/2008
2	prostacyclin synthetase (prostacyclin synthase)IBA 08/2006 - 10/2000
2	EnzymesIBA 12/2001 - 09/2000
2	ProstaglandinsIBA 12/2001 - 09/2000
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2001 - 06/2001
2	Fibronectins (Fibronectin)IBA 10/2001 - 01/2000
2	Messenger RNA (mRNA)IBA 02/2001 - 01/2000
1	Insulin (Novolin)FDA Link 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2014
1	Neutralizing AntibodiesIBA 04/2014
1	Interleukin-33IBA 04/2014
1	AntibodiesIBA 04/2014
1	Carbamazepine (Tegretol)FDA LinkGeneric 08/2011
1	Sodium Channels (Sodium Channel)IBA 08/2011
1	Gallium-67IBA 08/2009
1	Immunoglobulin G (IgG)IBA 08/2009
1	Immunoglobulins (Immunoglobulin)IBA 03/2009
1	Indicators and Reagents (Reagents)IBA 01/2009
1	Free RadicalsIBA 07/2006
1	EdaravoneIBA 07/2006
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2006
1	Free Radical ScavengersIBA 07/2006
1	von Willebrand FactorIBA 01/2006
1	FibrinIBA 01/2006
1	A-factor (Streptomyces)IBA 01/2006
1	Thromboplastin (Tissue Factor)IBA 01/2006
1	Capsules (Microcapsules)IBA 06/2004
1	Citrate (si)-Synthase (Synthase, Citrate)IBA 05/2003
1	Arachidonic Acid (Vitamin F)IBA 12/2001
1	EicosanoidsIBA 12/2001
1	Antiviral Agents (Antivirals)IBA 12/2001
1	voltage-dependent calcium channel (P-Q type)IBA 11/2001
1	technetium tc-99m tetrofosmin (Myoview)FDA Link 08/2001
1	Oncogene Proteins (Oncogene Protein)IBA 06/2001
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2001
1	Epstein-Barr virus EBV-associated membrane antigenIBA 06/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2001

Therapy/Procedure

3	Chemoradiotherapy 08/2003 - 05/2000
1	Epidural Blood Patch 01/2022
1	Curettage 07/2021
1	Off-Label Use 04/2014
1	Aftercare (After-Treatment) 12/2008
1	Nephrectomy 01/2006
1	Catheters 01/2006
1	Conservative Treatment 01/2004
1	Intravenous Infusions 08/2003
1	Intra-Arterial Infusions 08/2003